Literature DB >> 23599694

Further Evidence of Contrasting Phenotypes Caused by Reciprocal Deletions and Duplications: Duplication of NSD1 Causes Growth Retardation and Microcephaly.

J A Rosenfeld1, K H Kim, B Angle, R Troxell, J L Gorski, M Westemeyer, M Frydman, Y Senturias, D Earl, B Torchia, R A Schultz, J W Ellison, K Tsuchiya, S Zimmerman, T A Smolarek, B C Ballif, L G Shaffer.   

Abstract

Microduplications of the Sotos syndrome region containing NSD1 on 5q35 have recently been proposed to cause a syndrome of microcephaly, short stature and developmental delay. To further characterize this emerging syndrome, we report the clinical details of 12 individuals from 8 families found to have interstitial duplications involving NSD1, ranging in size from 370 kb to 3.7 Mb. All individuals are microcephalic, and height and childhood weight range from below average to severely restricted. Mild-to-moderate learning disabilities and/or developmental delay are present in all individuals, including carrier family members of probands; dysmorphic features and digital anomalies are present in a majority. Craniosynostosis is present in the individual with the largest duplication, though the duplication does not include MSX2, mutations of which can cause craniosynostosis, on 5q35.2. A comparison of the smallest duplication in our cohort that includes the entire NSD1 gene to the individual with the largest duplication that only partially overlaps NSD1 suggests that whole-gene duplication of NSD1 in and of itself may be sufficient to cause the abnormal growth parameters seen in these patients. NSD1 duplications may therefore be added to a growing list of copy number variations for which deletion and duplication of specific genes have contrasting effects on body development.

Entities:  

Keywords:  5q35; Duplication; Growth retardation; Microcephaly; NSD1; Sotos syndrome; aCGH

Year:  2013        PMID: 23599694      PMCID: PMC3569101          DOI: 10.1159/000345578

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  64 in total

1.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.

Authors:  Tamim H Shaikh; Xiaowu Gai; Juan C Perin; Joseph T Glessner; Hongbo Xie; Kevin Murphy; Ryan O'Hara; Tracy Casalunovo; Laura K Conlin; Monica D'Arcy; Edward C Frackelton; Elizabeth A Geiger; Chad Haldeman-Englert; Marcin Imielinski; Cecilia E Kim; Livija Medne; Kiran Annaiah; Jonathan P Bradfield; Elvira Dabaghyan; Andrew Eckert; Chioma C Onyiah; Svetlana Ostapenko; F George Otieno; Erin Santa; Julie L Shaner; Robert Skraban; Ryan M Smith; Josephine Elia; Elizabeth Goldmuntz; Nancy B Spinner; Elaine H Zackai; Rosetta M Chiavacci; Robert Grundmeier; Eric F Rappaport; Struan F A Grant; Peter S White; Hakon Hakonarson
Journal:  Genome Res       Date:  2009-07-10       Impact factor: 9.043

2.  Somatic activation of AKT3 causes hemispheric developmental brain malformations.

Authors:  Annapurna Poduri; Gilad D Evrony; Xuyu Cai; Princess Christina Elhosary; Rameen Beroukhim; Maria K Lehtinen; L Benjamin Hills; Erin L Heinzen; Anthony Hill; R Sean Hill; Brenda J Barry; Blaise F D Bourgeois; James J Riviello; A James Barkovich; Peter M Black; Keith L Ligon; Christopher A Walsh
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

3.  Microduplications upstream of MSX2 are associated with a phenocopy of cleidocranial dysplasia.

Authors:  Claus Eric Ott; Hendrikje Hein; Silke Lohan; Jeannette Hoogeboom; Nicola Foulds; Johannes Grünhagen; Sigmar Stricker; Pablo Villavicencio-Lorini; Eva Klopocki; Stefan Mundlos
Journal:  J Med Genet       Date:  2012-06-20       Impact factor: 6.318

4.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

5.  Identification of a 3.0-kb major recombination hotspot in patients with Sotos syndrome who carry a common 1.9-Mb microdeletion.

Authors:  Remco Visser; Osamu Shimokawa; Naoki Harada; Akira Kinoshita; Tohru Ohta; Norio Niikawa; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2004-11-16       Impact factor: 11.025

6.  Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull.

Authors:  Y H Liu; R Kundu; L Wu; W Luo; M A Ignelzi; M L Snead; R E Maxson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  Craniosynostosis in a patient with 2q37.3 deletion 5q34 duplication: association of extra copy of MSX2 with craniosynostosis.

Authors:  Ariana Kariminejad; Roxana Kariminejad; Andreas Tzschach; Reinhard Ullmann; Alisho Ahmed; Alaleh Asghari-Roodsari; Shadab Salehpour; Fariba Afroozan; Hans-Hilger Ropers; Mohammad Hasan Kariminejad
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

8.  P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.

Authors:  Alexey Fomenkov; Yi-Ping Huang; Ozlem Topaloglu; Anna Brechman; Motonobo Osada; Tanya Fomenkova; Eugene Yuriditsky; Barry Trink; David Sidransky; Edward Ratovitski
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

9.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities.

Authors:  Nicola Brunetti-Pierri; Jonathan S Berg; Fernando Scaglia; John Belmont; Carlos A Bacino; Trilochan Sahoo; Seema R Lalani; Brett Graham; Brendan Lee; Marwan Shinawi; Joseph Shen; Sung-Hae L Kang; Amber Pursley; Timothy Lotze; Gail Kennedy; Susan Lansky-Shafer; Christine Weaver; Elizabeth R Roeder; Theresa A Grebe; Georgianne L Arnold; Terry Hutchison; Tyler Reimschisel; Stephen Amato; Michael T Geragthy; Jeffrey W Innis; Ewa Obersztyn; Beata Nowakowska; Sally S Rosengren; Patricia I Bader; Dorothy K Grange; Sayed Naqvi; Adolfo D Garnica; Saunder M Bernes; Chin-To Fong; Anne Summers; W David Walters; James R Lupski; Pawel Stankiewicz; Sau Wai Cheung; Ankita Patel
Journal:  Nat Genet       Date:  2008-12       Impact factor: 38.330

10.  Genomic sister-disorders of neurodevelopment: an evolutionary approach.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Evol Appl       Date:  2009-01-07       Impact factor: 5.183

View more
  19 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

2.  19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.

Authors:  Aurélien Trimouille; Nada Houcinat; Marie-Laure Vuillaume; Patricia Fergelot; Cécile Boucher; Jérôme Toutain; Cédric Le Caignec; Marie Vincent; Mathilde Nizon; Joris Andrieux; Clémence Vanlerberghe; Bruno Delobel; Bénédicte Duban; Sahar Mansour; Emma Baple; Colina McKeown; Gemma Poke; Kate Robertshaw; Eve Fifield; Antonella Fabretto; Vanna Pecile; Paolo Gasparini; Marco Carrozzi; Didier Lacombe; Benoît Arveiler; Caroline Rooryck; Sébastien Moutton
Journal:  Eur J Hum Genet       Date:  2017-11-28       Impact factor: 4.246

Review 3.  Mechanisms underlying structural variant formation in genomic disorders.

Authors:  Claudia M B Carvalho; James R Lupski
Journal:  Nat Rev Genet       Date:  2016-02-29       Impact factor: 53.242

4.  Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.

Authors:  A Oguro-Ando; C Rosensweig; E Herman; Y Nishimura; D Werling; B R Bill; J M Berg; F Gao; G Coppola; B S Abrahams; D H Geschwind
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

5.  PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome.

Authors:  Julián Nevado; Jill A Rosenfeld; Rocío Mena; María Palomares-Bralo; Elena Vallespín; María Ángeles Mori; Jair A Tenorio; Karen W Gripp; Elizabeth Denenberg; Miguel Del Campo; Alberto Plaja; Rubén Martín-Arenas; Fernando Santos-Simarro; Lluis Armengol; Gordon Gowans; María Orera; M Carmen Sanchez-Hombre; Esther Corbacho-Fernández; Alberto Fernández-Jaén; Chad Haldeman-Englert; Sulagna Saitta; Holly Dubbs; Duban B Bénédicte; Xia Li; Lani Devaney; Mary Beth Dinulos; Stephanie Vallee; M Carmen Crespo; Blanca Fernández; Victoria E Fernández-Montaño; Inmaculada Rueda-Arenas; María Luisa de Torres; Jay W Ellison; Salmo Raskin; Carlos A Venegas-Vega; Fernando Fernández-Ramírez; Alicia Delicado; Sixto García-Miñaúr; Pablo Lapunzina
Journal:  Eur J Hum Genet       Date:  2015-04-08       Impact factor: 4.246

6.  Clinical and molecular heterogeneity in brazilian patients with sotos syndrome.

Authors:  Gustavo H Vieira; Melissa M Cook; Renata L Ferreira De Lima; Carlos E Frigério Domingues; Daniel R de Carvalho; Isaias Soares de Paiva; Danilo Moretti-Ferreira; Anand K Srivastava
Journal:  Mol Syndromol       Date:  2015-01-21

7.  Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders.

Authors:  Ching Moey; Susan J Hinze; Louise Brueton; Jenny Morton; Dominic J McMullan; Benjamin Kamien; Christopher P Barnett; Nicola Brunetti-Pierri; Jillian Nicholl; Jozef Gecz; Cheryl Shoubridge
Journal:  Eur J Hum Genet       Date:  2015-06-10       Impact factor: 4.246

Review 8.  The interplay between DNA and histone methylation: molecular mechanisms and disease implications.

Authors:  Yinglu Li; Xiao Chen; Chao Lu
Journal:  EMBO Rep       Date:  2021-04-12       Impact factor: 8.807

9.  Drosophila NSD deletion induces developmental anomalies similar to those seen in Sotos syndrome 1 patients.

Authors:  Saeyan Choi; Bokyeong Song; Hyewon Shin; Chihyun Won; Taejoon Kim; Hideki Yoshida; Daewon Lee; Jongkyeong Chung; Kyoung Sang Cho; Im-Soon Lee
Journal:  Genes Genomics       Date:  2021-04-17       Impact factor: 1.839

10.  Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Authors:  Sarah E Sinnett; Emily Boyle; Christopher Lyons; Steven J Gray
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.